From prescription-only (Rx) to over-the-counter (OTC) status in Germany 2006–2015: pharmacological perspectives on regulatory decisions-Reference-Cited by-同舟云学术

From prescription-only (Rx) to over-the-counter (OTC) status in Germany 2006–2015: pharmacological perspectives on regulatory decisions

Published:2017-03-28 Issue:7 Volume:73 Page:901-910
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Barrenberg Eva,Garbe Edeltraut

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/article/10.1007/s00228-017-2240-4/fulltext.html

Reference64 articles.

1. Bundesverband der Arzneimittelhersteller [German Medicines Manufacturers‘ Association] (2015) Der Arzneimittelmarkt in Deutschland: Zahlen und Fakten 2014 [The German pharmaceutical market: Facts and Figures 2014]. https://www.bah-bonn.de/index.php?eID=dumpFile&t=f&f=5526&token=8d393e946b928c6a85c98a1af98e6f2fc0fb5176 . Accessed 15.02.2016

2. Brass EP (2001) Changing the status of drugs from prescription to over-the-counter availability. N Engl J Med 345(11):810–816. doi: 10.1056/NEJMra011080

3. Bond CM, Orru MP, Leder JM, Bouvy M (2004) The over-the-counter pharmaceutical market. In: Mossialos E, Mrazek M, Walley T (eds) Regulating pharmaceuticals in Europe: striving for efficiency, equity and quality. Open University Press, Maidenhead, pp 260–278

4. Kennedy JG (1994) Over the counter drugs: Changing the roles of doctors and pharmacists. Editorial. BMJ 312:593–594

5. Francis S-A, Barnett N, Denham M (2005) Switching of prescription drugs to over-the-counter status: is it a good thing for the elderly? Drugs Ageing 22(5):361–370

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. „Diese Pillchen haben noch niemandem geschadet, die kann man bedenkenlos nehmen“ – eine typisierende Studie zu Einstellungen und Nutzungsgewohnheiten hausärztlicher Patient*innen in Bezug auf rezeptfreie Medikamente;Prävention und Gesundheitsförderung;2024-04-09

2. Real-world Data and Evidence to support a switch in status from Prescription drug to Over the Counter drug as applied by the EMA, the US FDA, the MHRA, and the BfArM;Clinical Therapeutics;2024-03

3. Attitudes, attributions, and usage patterns of primary care patients with regard to over-the-counter drugs—a survey in Germany;Wiener Medizinische Wochenschrift;2022-09-23

4. Community Attitudes and Habits Toward Over-The-Counter Drugs: Results of a Study Conducted in Thessaloniki, Greece;Value in Health Regional Issues;2022-03

5. The Awareness of Risks Associated with OTC Drugs Available in Non-Pharmacy Outlets among Polish Patients—A Cross-Sectional Study;Healthcare;2021-02-09